Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
Value Propositions
First Recipients of Bridge Grants to Support Hematologic Research Announced
Value Propositions
,
Value Peer-spectives
May 2013, Vol 4, No 4
Read Article
Powerful Algorithms Help Decipher the Genetics of Cancer
Value Propositions
,
Value Peer-spectives
May 2013, Vol 4, No 4
Using data-sifting algorithms developed by computer scientists at Brown University, researchers are beginning to untangle the complex genetics of cancer. In a new study published in the
New England Journal of Medicine,
investigators have outlined the most complete genetic profile of acute myeloid leukemia (AML).
Read Article
New Genomic Classification of Endometrial Cancers Will Soon Guide Therapy
Value Propositions
,
Value Peer-spectives
May 2013, Vol 4, No 4
Endometrial cancer is the fourth most common malignancy among American women. The National Cancer Institute estimates that close to 50,000 women will be diagnosed with endometrial cancer in 2013; for a majority of women with aggressive, high-grade tumors, the 5-year survival rate is approximately 16%.
Read Article
First Guidelines Issued for Molecular Diagnostics Use in Patients with Lung Cancer
Value Propositions
,
Value Peer-spectives
May 2013, Vol 4, No 4
After a decade of developing molecular diagnostics for lung cancer, 3 organizations have issued the first guidelines for testing for the EGFR mutation and ALK rearrangement in patients with lung cancer, the number one cancer-related killer worldwide, providing a valuable new tool to fully utilize the benefits of targeted therapies for this patient population.
Read Article
New Approach to Treatment Resistance in Head and Neck Cancers
Value Propositions
,
Value Peer-spectives
February 2013, Vol 4, No 2
The majority of head and neck tumors are associated with a deregulation of the PI3K/AKT/mTOR pathway, which has until now been seen as the culprit in treatment resistance in these cancers.
Read Article
HHS Allocates $1.9 Million to Establish Telehealth Programs for Underserved Populations
Value Propositions
,
Value Peer-spectives
February 2013, Vol 4, No 2
The HHS has allocated $1.9 million for new telehealth regional resource centers to serve rural and medically underserved populations.
Read Article
AACR Is Launching Cancer Immunology Research Journal
Value Propositions
,
Value Peer-spectives
February 2013, Vol 4, No 2
The American Association for Cancer Research (AACR) has announced the launch of its newest online journal, Cancer Immunology Research, in the spring at the AACR 2013 annual meeting.
Read Article
Starr Cancer Consortium Awards $5 Million to 5 Research Teams to Advance Patient Care
Value Propositions
,
Value Peer-spectives
February 2013, Vol 4, No 2
The Starr Foundation’s sixth Starr Cancer Consortium (SCC) Grant Competition awarded $5 million to 5 cancer research teams focusing on discovering new cancer mechanisms related to genetic mutations or epigenetic involvement in a variety of cancers.
Read Article
New Medicare Rules Will Save Providers $676 Million Annually
Value Propositions
,
Value Peer-spectives
February 2013, Vol 4, No 2
Removing Medicare regulations that are deemed unnecessary or unjustifiably burdensome on providers and hospitals would save nearly $676 million annually, and $3.4 billion over 5 years, through a rule proposed by the Centers for Medicare & Medicaid Services (CMS) in support of President Obama’s call on federal agencies to modify and streamline regulations on business.
Read Article
Novel Drug Targets Aggressive Form of NHL, Avoiding Chemotherapy a Goal
Value Propositions
,
Value Peer-spectives
January 2013, Vol 4, No 1
Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin lymphoma (NHL) and a common type of cancer.
Read Article
Page 5 of 11
1
2
3
4
5
6
7
8
9
10
View the Latest Issue of VBCC
Read Issue
Top Trending Articles
1.
Navigating the Complex Landscape of Oral Cancer Medication
2.
Luspatercept Yields Improved Transfusion Independence Compared With Epoetin Alfa in Patients With Lower-Risk MDS
Phoebe Starr
3.
New NCCN Guidelines for CLL/SLL Include Second-Generation BTK Inhibitors
Wayne Kuznar
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma